Traffic jam in the cell: How are proteins assigned to specific transporters?

About a third of all the proteins that are made in our cells start their lives in the endoplasmic reticulum, that serves as a general protein factory. However, most proteins are needed at other cellular locations and need to be transported there. To avoid a "traffic jam," cells have evolved transport vesicles that act as a public transportation system: Passengers -- the protein cargo -- need to present the correct ticket to board the right bus -- a specific type of vesicle -- and end up at the correct destination.

Scientists have known for decades that small vesicles that form on the surface of organelles package specific proteins and transport them to other areas of the cell or the cell surface. "Mutations in genes involved in vesicular transport often lead to disease. It is therefore crucial to understand which proteins are transported by which vesicles. Unfortunately transport vesicles have a short life span and are challenging to purify, so they are difficult to analyse," states Prof. Dr Felix Wieland, who headed up the research at the Heidelberg University Biochemistry Center (BZH).

The researchers combined two approaches to study the composition of the COPI and COPII vesicles in greater detail for the first time. A vesicle reconstitution procedure made it possible to produce and purify large amounts of vesicles. They also used stable isotope labelling with amino acids in cell cultures. This procedure -- called SILAC for short -- allows precisely quantifying different protein amounts using mass spectrometry.

"Being able to generate specific types of vesicles and to analyse their protein contents allowed us to define a catalogue of protein cargo for COPI and COPII vesicles. One key finding is that subtypes of COPII vesicles seem to have specialised in transporting certain types of proteins," stresses Dr Frank Adolf, the study's primary author. The researchers now hope that this approach will open the way to better understand how mutations that affect vesicular transport can lead to diseases.

As a member of the Cluster of Excellence CellNetworks at Ruperto Carola, Prof. Wieland's research at the Heidelberg University Biochemistry Center focuses on the mechanisms of vesicular transport and protein-lipid interactions.